Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis

By sjmartinez • April 4, 2023

Rastogi A, Fishbane S, Lerma E. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis. Expert Rev Clin Pharmacol. 2023 Apr 3. doi: 10.1080/17512433.2023.2197209. Epub ahead of print. PMID: 37010031.

Tags: Chronic kidney disease, chronic kidney disease-associated pruritus, difelikefalin, efficacy, kappa opioid receptor, Nephrology, opioids, pruritus, Publications, safety

Uptake of Peritoneal Dialysis (PD) by Minoritized Patients: The Role of Modality Education

Arnaoudova I, Wilson C, Rizzolo K, Shen J, Ehtesham N, Wilson J, Golestaneh L. Uptake of Peritoneal Dialysis (PD) by Minoritized Patients: The Role of[...]

Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel

Henner DE, Drambarean B, Gerbeling TM, Kendrick JB, Kendrick WT, Koester-Wiedemann L, Nickolas TL, Rastogi A, Rauf AA, Dyson B, Singer MC, Desai P, Fox[...]

Health Equity and Artificial Intelligence in Nephrology

Hercz AE, Nicholas SB, Bui AAT, Norris KC. Health Equity and Artificial Intelligence in Nephrology. Clin J Am Soc Nephrol. 2025 Jan 28. doi: 10.2215/CJN.0000000673.[...]